|
AU7667498A
(en)
*
|
1997-05-30 |
1998-12-30 |
Celltech Therapeutics Limited |
Anti-inflammatory tyrosine derivatives
|
|
US6291453B1
(en)
|
1997-07-31 |
2001-09-18 |
Athena Neurosciences, Inc. |
4-amino-phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6362341B1
(en)
|
1997-07-31 |
2002-03-26 |
Athena Neurosciences, Inc. |
Benzyl compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6583139B1
(en)
|
1997-07-31 |
2003-06-24 |
Eugene D. Thorsett |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6492421B1
(en)
|
1997-07-31 |
2002-12-10 |
Athena Neurosciences, Inc. |
Substituted phenylalanine type compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6939855B2
(en)
|
1997-07-31 |
2005-09-06 |
Elan Pharmaceuticals, Inc. |
Anti-inflammatory compositions and method
|
|
US6423688B1
(en)
|
1997-07-31 |
2002-07-23 |
Athena Neurosciences, Inc. |
Dipeptide and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6559127B1
(en)
|
1997-07-31 |
2003-05-06 |
Athena Neurosciences, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US6489300B1
(en)
|
1997-07-31 |
2002-12-03 |
Eugene D. Thorsett |
Carbamyloxy compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
US7030114B1
(en)
|
1997-07-31 |
2006-04-18 |
Elan Pharmaceuticals, Inc. |
Compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
DE19741235A1
(de)
|
1997-09-18 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
DE19741873A1
(de)
*
|
1997-09-23 |
1999-03-25 |
Hoechst Marion Roussel De Gmbh |
Neue 5-Ring-Heterocyclen, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
WO1999023063A1
(en)
|
1997-10-31 |
1999-05-14 |
Aventis Pharma Limited |
Substituted anilides
|
|
GB9723789D0
(en)
|
1997-11-12 |
1998-01-07 |
Zeneca Ltd |
Chemical compounds
|
|
DE19751251A1
(de)
|
1997-11-19 |
1999-05-20 |
Hoechst Marion Roussel De Gmbh |
Substituierte Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmezeutische Präparate
|
|
US6645939B1
(en)
|
1997-11-24 |
2003-11-11 |
Merck & Co., Inc. |
Substituted β-alanine derivatives as cell adhesion inhibitors
|
|
AU751950B2
(en)
*
|
1997-11-24 |
2002-09-05 |
Merck & Co., Inc. |
Substituted beta-alanine derivatives as cell adhesion inhibitors
|
|
US6407065B1
(en)
|
1998-01-23 |
2002-06-18 |
Novartis Ag |
VLA-4 antagonists
|
|
US6329372B1
(en)
|
1998-01-27 |
2001-12-11 |
Celltech Therapeutics Limited |
Phenylalanine derivatives
|
|
GB9805655D0
(en)
|
1998-03-16 |
1998-05-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6521626B1
(en)
|
1998-03-24 |
2003-02-18 |
Celltech R&D Limited |
Thiocarboxamide derivatives
|
|
AU3748399A
(en)
|
1998-04-16 |
1999-11-01 |
Texas Biotechnology Corporation |
N,n-disubstituted amides that inhibit the binding of integrins to their receptors
|
|
DE19821483A1
(de)
|
1998-05-14 |
1999-11-18 |
Hoechst Marion Roussel De Gmbh |
Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
GB9811159D0
(en)
|
1998-05-22 |
1998-07-22 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
CN1148350C
(zh)
*
|
1998-05-28 |
2004-05-05 |
拜奥根有限公司 |
新型VLA-4抑制剂:oMePUPA-V
|
|
GB9811969D0
(en)
*
|
1998-06-03 |
1998-07-29 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9814414D0
(en)
|
1998-07-03 |
1998-09-02 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
WO2000002903A1
(en)
*
|
1998-07-10 |
2000-01-20 |
Cytel Corporation |
Cs-1 peptidomimetics, compositions and methods of using the same
|
|
US6352977B1
(en)
|
1998-07-13 |
2002-03-05 |
Aventis Pharma Limited |
Substituted β-alanines
|
|
GB9916374D0
(en)
|
1998-07-23 |
1999-09-15 |
Zeneca Ltd |
Chemical compounds
|
|
GB9821061D0
(en)
|
1998-09-28 |
1998-11-18 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9821222D0
(en)
|
1998-09-30 |
1998-11-25 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9825652D0
(en)
|
1998-11-23 |
1999-01-13 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
GB9826174D0
(en)
|
1998-11-30 |
1999-01-20 |
Celltech Therapeutics Ltd |
Chemical compounds
|
|
US6407066B1
(en)
|
1999-01-26 |
2002-06-18 |
Elan Pharmaceuticals, Inc. |
Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by VLA-4
|
|
GB9909409D0
(en)
*
|
1999-04-24 |
1999-06-23 |
Zeneca Ltd |
Chemical compounds
|
|
JP4707240B2
(ja)
*
|
1999-05-05 |
2011-06-22 |
アベンティス・フアーマ・リミテッド |
細胞接着調節剤としての尿素
|
|
RO121640B1
(ro)
*
|
1999-05-07 |
2008-01-30 |
Texas Biotechnology Corporation |
Derivaţi de acid propionic ce inhibă legarea integrinelor de receptorii acestora, compoziţie farmaceutică ce îi conţine şi utilizare a acesteia
|
|
US6723711B2
(en)
|
1999-05-07 |
2004-04-20 |
Texas Biotechnology Corporation |
Propanoic acid derivatives that inhibit the binding of integrins to their receptors
|
|
US6972296B2
(en)
|
1999-05-07 |
2005-12-06 |
Encysive Pharmaceuticals Inc. |
Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
|
|
JP3620577B2
(ja)
*
|
1999-05-14 |
2005-02-16 |
栗田工業株式会社 |
超純水製造システムの洗浄方法
|
|
DE19922462A1
(de)
|
1999-05-17 |
2000-11-23 |
Aventis Pharma Gmbh |
Spiro-imidazolidinderivate, ihre Herstellung ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
US6518283B1
(en)
|
1999-05-28 |
2003-02-11 |
Celltech R&D Limited |
Squaric acid derivatives
|
|
US6756378B2
(en)
|
1999-06-30 |
2004-06-29 |
Pharmacopeia Drug Discovery, Inc. |
VLA-4 inhibitor compounds
|
|
WO2001004103A1
(en)
|
1999-07-13 |
2001-01-18 |
F. Hoffmann-La Roche Ag |
Benzazepinones and quinazolines
|
|
HUP0202469A3
(en)
|
1999-08-13 |
2004-06-28 |
Biogen Idec Ma Inc Cambridge |
Cell adhesion inhibitor compound and pharmaceutical composition containing thereof
|
|
CA2384948C
(en)
*
|
1999-09-14 |
2013-07-16 |
Biogen, Inc. |
Therapies for chronic renal failure using one or more integrin antagonists
|
|
EP1700606A1
(en)
*
|
1999-09-14 |
2006-09-13 |
Biogen Idec MA, Inc. |
Therapies for chronic renal failure using one or more integrin antagonists
|
|
US6534513B1
(en)
|
1999-09-29 |
2003-03-18 |
Celltech R&D Limited |
Phenylalkanoic acid derivatives
|
|
JP2003516380A
(ja)
*
|
1999-12-07 |
2003-05-13 |
ノバルティス アクチエンゲゼルシャフト |
Ｖｌａ−４インテグリンアンタゴニスト
|
|
US6455539B2
(en)
|
1999-12-23 |
2002-09-24 |
Celltech R&D Limited |
Squaric acid derivates
|
|
NZ518886A
(en)
|
1999-12-28 |
2004-02-27 |
Pfizer Prod Inc |
Non-peptidyl inhibitors of VLA-4 dependent cell binding useful in treating inflammatory, autoimmune, and respiratory diseases
|
|
GB0001348D0
(en)
*
|
2000-01-21 |
2000-03-08 |
Astrazeneca Uk Ltd |
Chemical compounds
|
|
DE10006453A1
(de)
*
|
2000-02-14 |
2001-08-16 |
Bayer Ag |
Piperidylcarbonsäuren als Integrinantagonisten
|
|
ATE375330T1
(de)
|
2000-04-17 |
2007-10-15 |
Ucb Pharma Sa |
Enamin-derivate als zell-adhäsionsmoleküle
|
|
GB0011817D0
(en)
*
|
2000-05-16 |
2000-07-05 |
Pharmacia & Upjohn Spa |
Antagonists of integrin receptors
|
|
US6403608B1
(en)
|
2000-05-30 |
2002-06-11 |
Celltech R&D, Ltd. |
3-Substituted isoquinolin-1-yl derivatives
|
|
US6545013B2
(en)
|
2000-05-30 |
2003-04-08 |
Celltech R&D Limited |
2,7-naphthyridine derivatives
|
|
US7065453B1
(en)
|
2000-06-15 |
2006-06-20 |
Accelrys Software, Inc. |
Molecular docking technique for screening of combinatorial libraries
|
|
AU2001268607A1
(en)
|
2000-06-21 |
2002-01-02 |
Bristol-Myers Squibb Company |
Piperidine amides as modulators of chemokine receptor activity
|
|
JP2004502762A
(ja)
|
2000-07-07 |
2004-01-29 |
セルテック アール アンド ディ リミテッド |
二環性ヘテロ芳香環を含有するインテグリンアンタゴニストとしてのスクエア酸誘導体
|
|
WO2002010136A1
(en)
|
2000-08-02 |
2002-02-07 |
Celltech R & D Limited |
3-substituted isoquinolin-1-yl derivatives
|
|
GB2369357A
(en)
*
|
2000-10-09 |
2002-05-29 |
Bayer Ag |
Aliphatic, cyclic amino carboxylic acids as integrin antagonists
|
|
CN1592746A
(zh)
|
2000-11-28 |
2005-03-09 |
杰南技术公司 |
Lfa－1拮抗剂化合物
|
|
IL156064A0
(en)
|
2000-12-28 |
2003-12-23 |
Daiichi Seiyaku Co |
Vla-4 inhibitors
|
|
ES2200617B1
(es)
|
2001-01-19 |
2005-05-01 |
Almirall Prodesfarma, S.A. |
Derivados de urea como antagonistas de integrinas alfa 4.
|
|
SI1379520T1
(sl)
|
2001-02-23 |
2006-08-31 |
Merck & Co Inc |
N-substituirani nonaril-heterociklicni NMDA/NR2B antagonisti
|
|
DE10111877A1
(de)
|
2001-03-10 |
2002-09-12 |
Aventis Pharma Gmbh |
Neue Imidazolidinderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
|
|
CA2443108A1
(en)
|
2001-04-03 |
2002-10-17 |
Merck & Co. Inc. |
N-substituted nonaryl-heterocyclo amidyl nmda/nr2b antagonists
|
|
US7056917B2
(en)
|
2001-04-26 |
2006-06-06 |
Daiichi Pharmaceutical Co., Ltd. |
Drug efflux pump inhibitor
|
|
GB2377933A
(en)
*
|
2001-07-06 |
2003-01-29 |
Bayer Ag |
Succinic acid derivatives useful as integrin antagonists
|
|
DE10137595A1
(de)
|
2001-08-01 |
2003-02-13 |
Aventis Pharma Gmbh |
Neue Imidazolidinderivate, ihre Herstellung und ihre Verwendung
|
|
CA2770493A1
(en)
|
2003-07-24 |
2005-02-03 |
Daiichi Pharmaceutical Co., Ltd. |
Cyclohexanecarboxylic acid compound
|
|
US20070149607A1
(en)
*
|
2003-12-26 |
2007-06-28 |
Daichi Paharmaceutical Co., Ltd. |
Method for producing pyrrolidine derivative
|
|
US7196112B2
(en)
|
2004-07-16 |
2007-03-27 |
Biogen Idec Ma Inc. |
Cell adhesion inhibitors
|
|
GB0517292D0
(en)
*
|
2005-08-24 |
2005-10-05 |
Univ Dundee |
Cell migration modulating compounds
|
|
EP2510941A3
(en)
|
2007-02-20 |
2013-01-23 |
Merrimack Pharmaceuticals, Inc. |
Methods of treating multiple sclerosis by administration of alpha-fetoprotein in combination with an integrin antagonist
|
|
JP2010520875A
(ja)
|
2007-03-09 |
2010-06-17 |
レノビス， インコーポレイテッド |
Ｐ２ｘ７調節因子としてのビシクロヘテロアリール化合物およびその使用
|
|
ES2525065T3
(es)
|
2008-04-11 |
2014-12-17 |
Merrimack Pharmaceuticals, Inc. |
Ligadores de seroalbúmina humana y sus conjugados
|
|
US8563690B2
(en)
|
2008-11-03 |
2013-10-22 |
The Board Of Trustees Of The University Of Illinois |
Modulation of platelet aggregation
|
|
ME02793B
(me)
|
2010-04-16 |
2018-01-20 |
Biogen Ma Inc |
Anti-vla-4 antitijela
|
|
US20140094512A1
(en)
|
2012-10-02 |
2014-04-03 |
Nikolas Gunkel |
Method of modulating the degree of adipose tissue deposited intramuscularly
|
|
US10875875B2
(en)
|
2017-04-26 |
2020-12-29 |
Aviara Pharmaceuticals, Inc. |
Propionic acid derivatives and methods of use thereof
|
|
EP3800999A4
(en)
|
2018-06-04 |
2022-06-01 |
Biogen MA Inc. |
ANTI-VLA-4 ANTIBODY WITH REDUCED EFFECTIVE FUNCTION
|
|
CN112969700B
(zh)
|
2018-10-30 |
2024-08-20 |
吉利德科学公司 |
作为α4β7整合素抑制剂的咪唑并吡啶衍生物
|
|
BR112021007213A2
(pt)
|
2018-10-30 |
2021-08-10 |
Gilead Sciences, Inc. |
derivados de quinolina como inibidores de integrina alfa4beta7
|
|
ES3003232T3
(en)
|
2018-10-30 |
2025-03-10 |
Gilead Sciences Inc |
Compounds for inhibition of alpha4beta7 integrin
|
|
CA3115820A1
(en)
|
2018-10-30 |
2020-05-07 |
Gilead Sciences, Inc. |
Compounds for inhibition of .alpha.4.beta.7 integrin
|
|
EP4013499A1
(en)
|
2019-08-14 |
2022-06-22 |
Gilead Sciences, Inc. |
Compounds for inhibition of alpha 4 beta 7 integrin
|